Denmark· DK-28106150618
Tigecycline "Accord"
A tigecycline product containing tigecyclin, registered in Denmark by Accord Healthcare S.L.U.. The same ATC class is registered in 17 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Tigecycline is registered in 17 of 19 countries.
Countries holding a registration under ATC J01AA12 (tigecycline), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Tigecycline · ATC J01AA12
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tigecycline costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tigecycline · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FI Finland$3.05
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Tigecyclin
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Denmark (DK)
- ATC code
- J01AA12
- ATC class
- Tigecycline
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106150618
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for tigecycline.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tigecycline · interactions on record
65 records
- 3 severe
- 13 moderate
- 24 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- Sodium picosulfateA06AB08moderate
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01AA12
Tigecycline, as other registers publish it.
- GermanyTigecyclin AmaroxAmarox Pharma Gmbh
- GermanyTigecyclin CarinopharmCarinopharm Gmbh
- GermanyTigecyclin CiplaCipla Europe Nv
- GermanyTigecyclin HikmaHikma Farmacêutica (Portugal), S.A.
- SwitzerlandTigecyclin Leman 50 mg , Poudre pour solution à diluer pour perfusionLeman SKL SA
- GermanyTigecyclin LyomarkBendalis Gmbh
- GermanyTigecyclin MylanMylan Germany Gmbh
- GermanyTigecyclin MylanViatris Germany Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bab0cead-131f-4c32-a387-644717d767f6 GET /v1/drugs/bab0cead-131f-4c32-a387-644717d767f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til infusionsvæske, opløsning",
"source": "dkma",
"strength": "50 mg",
"auth_role": "MOD",
"dk_drugid": "28106150618",
"substance": "Tigecyclin",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43938"
}See everything about tigecycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.